CA51164-1 - 0x000000000000746F

Healthy Males & Females

Lark

* Stipend may pay up to reflected amount.
Start Date: 
December 1, 2026 - 1:45pm
End Date: 
December 30, 2026 - 9:00am

Study Details

Study Number: CA51164
Group Number: 1
Study Requirement: Healthy Normal Male and Female
Stipend: up to $4,250.00

Study Criteria

Age: 19 - 55
BMI: 27 - 39.9
Weight Restriction: minimum weight 0 lbs

Study Information

Indication: This investigational medication is being developed to lower glucose and aid weight loss.
Route of Administration: Injection subcutaneous

Study Schedule

Schedule Type: Short stays with returns
Study Length: 4 Night Stay & 5 Returns

Screening Dates:

Event Day Event Date
Wednesday 11/18/2026
Tuesday 11/24/2026
Monday 11/30/2026

Doctor Exam Dates:

Event Day Event Date
Wednesday 11/18/2026
Tuesday 11/24/2026
Monday 11/30/2026

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Tuesday 12/1/2026 1:45:00 PM Saturday 12/5/2026 8:45:00 AM 1 Lincoln
Return Wednesday 12/9/2026 7:15:00 AM Wednesday 12/9/2026 8:45:00 AM 1 Lincoln
Return Saturday 12/12/2026 7:15:00 AM Saturday 12/12/2026 8:15:00 AM 1 Lincoln
Return Wednesday 12/16/2026 7:15:00 AM Wednesday 12/16/2026 8:15:00 AM 1 Lincoln
Return Wednesday 12/23/2026 7:15:00 AM Wednesday 12/23/2026 8:15:00 AM 1 Lincoln
Return Wednesday 12/30/2026 7:15:00 AM Wednesday 12/30/2026 9:00:00 AM 1 Lincoln